T cells as mediators of protective immunity against liver stages of Plasmodium (Q35066264)

6 August 2017

1 reference

title

T cells as mediators of protective immunity against liver stages of Plasmodium (English)

1 reference

6 August 2017

Moriya Tsuji

0 references

Fidel Zavala

1 reference

6 August 2017

publication date

1 February 2003

1 reference

6 August 2017

published in

Trends in Parasitology

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

88-93

1 reference

Rationale for the development of an engineered sporozoite malaria vaccine

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Molecular analysis of the association of HLA-B53 and resistance to severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

HLA-A*01-restricted cytotoxic T-lymphocyte epitope from the Plasmodium falciparum circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Association of malaria parasite population structure, HLA, and immunological antagonism.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

CD8+ T Cell Effector Mechanisms in Resistance to Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

The role of intrahepatic lymphocytes in mediating protective immunity induced by attenuated Plasmodium berghei sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

DNA-based vaccines against malaria: status and promise of the Multi-Stage Malaria DNA Vaccine Operation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

A striking property of recombinant poxviruses: efficient inducers of in vivo expansion of primed CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Multiple T helper cell epitopes of the circumsporozoite protein of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Human T-cell recognition of the circumsporozoite protein of plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Cutting edge: the IgG response to the circumsporozoite protein is MHC class II-dependent and CD1d-independent: exploring the role of GPIs in NK T cell activation and antimalarial responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Sporozoite antigens: biology and immunology of the circumsporozoite protein and thrombospondin-related anonymous protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

CD4+ cytolytic T cell clone confers protection against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

gammadelta T cells are a component of early immunity against preerythrocytic malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

CD1d-restricted NK T cells are dispensable for specific antibody responses and protective immunity against liver stage malaria infection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2802%2900053-3

7 January 2021

10.1016/S1471-4922(02)00053-3

Identifiers

DOI

1 reference

6 August 2017

1 reference